Documentation centre - My Healthy Waist

Key Publications February 2, 2021

Association between triglycerides and residual cardiovascular risk in patients with type 2 diabetes mellitus and established cardiovascular disease (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] trial).

Am J Cardiol. 2020;132:36-43

Nelson AJ, Navar AM, Mulder H, Wojdyla D, Philip S, Granowitz C, Peterson ED, Pagidipati NJ

Key Publications January 27, 2021

Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease.

Atherosclerosis. 2020;308:1-5

Jung I, Kwon H, Park SE, Park CY, Lee WY, Oh KW, Park SW, Rhee EJ

Ectopic Fat Insulin Resistance Lipids/Lipoproteins

Key Publications January 26, 2021

Targeting Lp(a) to reduce ASCVD risk.

Nat Rev Cardiol. 2020;17:612

Huynh K

Cardiovascular Disease Lipids/Lipoproteins Prevention

Key Publications January 19, 2021

2019 vs. 2016 ESC/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease.

Eur Heart J. 2020;41:3005-3015

Mortensen MB, Nordestgaard BG

Cardiovascular Disease Lipids/Lipoproteins Prevention

Key Publications January 19, 2021

Prevention of cardiovascular disease: time for a course correction.

Eur Heart J. 2020;41:3016-3017

Sniderman AD, Thanassoulis G, Pencina M

Cardiovascular Disease Lipids/Lipoproteins Prevention

Key Publications January 18, 2021

Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial.

Eur Heart J. 2020;41:2952-2961

Ridker PM, MacFadyen JG, Glynn RJ, Bradwin G, Hasan AA, Rifai N

Cardiovascular Disease Inflammation Lipids/Lipoproteins

Key Publications January 18, 2021

Persistent inflammatory residual risk despite aggressive cholesterol-lowering therapy: further evidence fuelling the dual target concept.

Eur Heart J. 2020;41:2962-2964

Koenig W

Cardiovascular Disease Inflammation Lipids/Lipoproteins

Key Publications January 15, 2021

Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease.

J Lipid Res. 2020;61:1254-1262

Cao YX, Zhang HW, Jin JL, Liu HH, Zhang Y, Xu RX, Gao Y, Guo YL, Zhu CG, Hua Q, Li YF, Santos RD, Wu NQ, Li JJ

Cardiovascular Disease Lipids/Lipoproteins Prevention

Key Publications January 4, 2021

Lipids and lipoproteins in 2020.

JAMA. 2020;324:595-596

Ference BA, Kastelein JJP, Catapano AL

Cardiovascular Disease Lipids/Lipoproteins Metabolism

Key Publications December 29, 2020

Saturated fats and health: A reassessment and proposal for food-based recommendations: JACC state-of-the-art review.

J Am Coll Cardiol. 2020;76:844-857

Astrup A, Magkos F, Bier DM, Brenna JT, de Oliveira Otto MC, Hill JO, King JC, Mente A, Ordovas JM, Volek JS, Yusuf S, Krauss RM

Cardiovascular Disease Lipids/Lipoproteins Nutrition

Key Publications December 28, 2020

Lipoprotein(a) and family history predict cardiovascular disease risk.

J Am Coll Cardiol. 202;76:781-793

Mehta A, Virani SS, Ayers CR, Sun W, Hoogeveen RC, Rohatgi A, Berry JD, Joshi PH, Ballantyne CM, Khera A

Cardiovascular Disease Genetics Lipids/Lipoproteins

Key Publications December 28, 2020

Family history and lipoprotein(a) contribute independently to risk assessment and clinical management.

J Am Coll Cardiol. 2020;76:794-796

Durrington PN

Cardiovascular Disease Genetics Lipids/Lipoproteins